Atlas Trials

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

Clinical trial NCT00239967 · COMPLETED

Trial details

NCT number
NCT00239967
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DyslipidemiaObesity
Start date
2005-05-01
Primary completion
2007-02-01
Enrollment
803

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.